Nu-Med Plus (NUMD) Notes Payables (2012 - 2025)

Nu-Med Plus (NUMD) reported Notes Payables of $100000.0 for Q4 2025, little changed on a YoY basis from $100000.0 in Q4 2024, and little changed sequentially from $100000.0 in Q3 2025.

Nu-Med Plus (NUMD) Notes Payables (2012 - 2025) Analysis & Trends

Nu-Med Plus (NUMD) has 14 years of Notes Payables data on file, last reported at $100000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Notes Payables changed 0.0% year-over-year to $100000.0; the trailing twelve-month figure through Dec 2025 stood at $100000.0 (changed 0.0% YoY), and the FY2025 full-year result was $100000.0, changed 0.0% from the prior year.
  • Notes Payables held at $100000.0 in Q4 2025, from $100000.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $100000.0 in Q4 2022 to a low of $20000.0 in Q3 2021.
  • A 5-year average of $77937.0 and a median of $100000.0 in 2022 frame the typical range for Notes Payables.
  • Across the five-year window, Notes Payables tumbled 91.31% in 2021 and surged 284.62% in 2022, its largest moves.
  • Tracing NUMD's Notes Payables over 5 years: stood at $26000.0 in 2021, then surged by 284.62% to $100000.0 in 2022, then changed by 0.0% to $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025.
  • Business Quant data shows NUMD's Notes Payables at $100000.0 in Q4 2025, $100000.0 in Q3 2025, and $100000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn
10 Nu-Med Plus 1.67 Mn 1.67 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 100,000.00
Sep 30, 2025 100,000.00
Jun 30, 2025 100,000.00
Mar 31, 2025 100,000.00
Dec 31, 2024 100,000.00
Sep 30, 2024 100,000.00
Jun 30, 2024 100,000.00
Mar 31, 2024 100,000.00
Dec 31, 2023 100,000.00
Sep 30, 2023 100,000.00
Jun 30, 2023 100,000.00
Mar 31, 2023 100,000.00
Dec 31, 2022 100,000.00
Sep 30, 2022 69,378.00
Jun 30, 2022 59,361.00
Mar 31, 2022 32,000.00
Dec 31, 2021 26,000.00
Sep 30, 2021 20,000.00
Jun 30, 2021 26,000.00
Mar 31, 2021 26,000.00